E
DBTX

Ergoteles’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Ergoteles’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-23,480
Closed -$48.1K – 1935
2022
Q4 		$48.1K Buy
+23,480
New +$71.5K ﹤0.01% 1295
2021
Q4 		– Sell
-19,968
Closed -$154K – 1699
2021
Q3 		$154K Buy
+19,968
New +$152K 0.01% 1049

Other funds holding DBTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $4.26B AUM 5.81% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Ergoteles's DBTX Position: Q1 2023 in Review

Ergoteles sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q1 2023, closing a stake of 23,480 shares — an estimated $48.1K sold.

Ergoteles first reported a position in DBTX in Q3 2021 and held it in 2 quarters. The position peaked at $154K in Q3 2021. 38 funds tracked by Wall St. Rank hold DBTX as of Q1 2023.

  • Ergoteles reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 23,480 Decibel Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $48.1K.
  • Ergoteles first reported a position in Decibel Therapeutics, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Ergoteles's Decibel Therapeutics, Inc. Common Stock position peaked at $154K in Q3 2021.
  • 38 funds tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.